2023
2022
2021
An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancer. Nat Comm. 2021 Apr 16;12(1):230 doi: 10.1038/s41467-021-22465-w.
γδ T Cells Support Antigen-Specific αβ T cell-Mediated Antitumor Responses during BCG Treatment for Bladder Cancer. Cancer Immunol Res 2021 Dec;9(12):1491-1503. doi: 10.1158/2326-6066.CIR-21-0285. Epub 2021 Oct 4
Subtype-associated epigenomic landscape and 3D genome structure in bladder cancer.Genome Biol. 2021 Apr 15;22(1):105. doi: 10.1186/s13059-021-02325-y.
MutSignatures: an R package for extraction and analysis of cancer mutational signatures. Sci Rep. 2020 Oct 26;10(1):18217. doi: 10.1038/s41598-020-75062-0.
Identification of Differential Tumor Subtypes of T1 Bladder Cancer. Eur Urol. 2020 Oct;78(4):533-537. doi: 10.1016/j.eururo.2020.06.048. Epub 2020 Jul 17.
Surgeon Scorecards Improve Muscle Sampling on Transurethral Resection of Bladder Tumor and Recurrence Outcomes in Patients with Nonmuscle Invasive Bladder Cancer. J Urol. 2021 Mar;205(3):693-700. doi: 10.1097/JU.0000000000001372. Epub 2020 Oct 6.
A compilation of all publications can be found on PubMed or Google Scholar.